Showing results (251-260 of 334) with videos related to

Sort By:
Pageof 34
Nature Medicine|July 1, 2026
A meta-analysis of the long-term effects of antihypertensive therapy on the risk of major cardiovascular disease across 51 randomized trialsQianqian Yang, Zeinab Bidel, Dexter Canoy, et al.
European Journal of Clinical Nutrition|February 24, 2024
The effect of salt substitution on frequency and severity of headache: results from the SSaSS cluster-randomised controlled trial of 20,995 participantsFaraidoon Haghdoost, Sonali R Gnanenthiran, Sana Shan, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 2, 2025
Statistical Analysis Plan for a Randomized Controlled Trial of Intensive Blood Pressure Control on Cardiovascular risk Reduction in Patients with Atrial FibrillationXiaolei Lin, Chao Jiang, Zhiyan Wang, et al.
Contemporary Clinical Trials|July 23, 2011
IMProving Adherence using Combination Therapy (IMPACT): design and protocol of a randomised controlled trial in primary careVanessa Selak, C Raina Elley, Sue Crengle, et al.
Nature Medicine|March 27, 2024
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseaseAnubha Agarwal, Priya M Mehta, Tyler Jacobson, et al.
BMC Public Health|November 17, 2018
Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural IndiaDevarsetty Praveen, David Peiris, Stephen MacMahon, et al.
Kidney International Reports|February 12, 2024
The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice DatasetMin Jun, James Wick, Brendon L Neuen, et al.
Hypertension (Dallas, Tex. : 1979)|December 21, 2018
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes MellitusToshiaki Ohkuma, Min Jun, Anthony Rodgers, et al.
Lancet (London, England)|November 13, 2015
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysisXinfang Xie, Emily Atkins, Jicheng Lv, et al.
The Lancet. HIV|November 20, 2019
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trialJean-Michel Molina, Kathleen Squires, Paul E Sax, et al.
Pageof 34